CDA | Evidence Driven
CDA | Evidence Driven

Somatropin

Details

Files
Project Status:
Completed
Project Line:
Health Technology Review
Project Sub Line:
Technology Review
Project Number:
HC0068-000
Effective finish date:

We are convening an implementation advice panel to advise the drug programs on funding criteria for somatropin for growth hormone deficiency in children and adults, idiopathic short stature, Turner syndrome, and short stature secondary to small for gestational age. This advice will be used by drug programs for decision-making on criteria for the reimbursement of somatropin for the previously mentioned indications.

Files

Final Report View PDF
Last Updated : July 12, 2024